RNS Number : 4351B
PureTech Health PLC
31 January 2024
 

31 January 2024

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:             

30 January 2024



Number of ordinary shares purchased:

58,677



Highest price paid per share:

201.50p



Lowest price paid per share:

195.20p



Volume weighted average price paid per share:

198.31p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 19,116,082 ordinary shares in treasury and has 270,352,077 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 270,352,077 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

30/01/2024

08:19:43

988

201

XLON

00387754716TRLO0.1.1

30/01/2024

08:22:06

205

200.5

XLON

00387755474TRLO0.1.1

30/01/2024

08:33:54

1976

201.5

XLON

00387758762TRLO0.1.1

30/01/2024

08:33:54

131

201.5

TRQX

00387758763TRLO0.1.1

30/01/2024

08:35:21

246

201

AQXE

00387759255TRLO0.1.1

30/01/2024

08:35:21

494

201

CHIX

00387759256TRLO0.1.1

30/01/2024

08:35:21

494

201

CHIX

00387759257TRLO0.1.1

30/01/2024

08:35:21

1277

201

XLON

00387759258TRLO0.1.1

30/01/2024

08:35:26

494

200.5

BATE

00387759300TRLO0.1.1

30/01/2024

08:39:25

494

200

XLON

00387760551TRLO0.1.1

30/01/2024

08:50:26

83

199.2

XLON

00387763066TRLO0.1.1

30/01/2024

08:50:26

411

199.2

XLON

00387763067TRLO0.1.1

30/01/2024

08:50:26

428

199.2

XLON

00387763068TRLO0.1.1

30/01/2024

08:50:26

66

199.2

XLON

00387763069TRLO0.1.1

30/01/2024

08:56:16

494

199

XLON

00387764083TRLO0.1.1

30/01/2024

08:56:30

130

199

XLON

00387764131TRLO0.1.1

30/01/2024

08:56:30

380

198.8

XLON

00387764132TRLO0.1.1

30/01/2024

09:19:11

494

198.4

BATE

00387768816TRLO0.1.1

30/01/2024

09:19:11

90

198.4

BATE

00387768817TRLO0.1.1

30/01/2024

09:19:11

478

198.4

XLON

00387768818TRLO0.1.1

30/01/2024

09:19:11

135

198.4

XLON

00387768819TRLO0.1.1

30/01/2024

09:19:11

359

198.4

XLON

00387768820TRLO0.1.1

30/01/2024

09:19:11

494

198.4

XLON

00387768821TRLO0.1.1

30/01/2024

09:19:32

134

197.8

CHIX

00387768902TRLO0.1.1

30/01/2024

09:19:32

360

197.8

CHIX

00387768903TRLO0.1.1

30/01/2024

09:59:19

246

198

AQXE

00387776513TRLO0.1.1

30/01/2024

09:59:19

494

198

CHIX

00387776512TRLO0.1.1

30/01/2024

09:59:19

131

198

TRQX

00387776514TRLO0.1.1

30/01/2024

09:59:19

494

198

XLON

00387776515TRLO0.1.1

30/01/2024

09:59:19

990

198

XLON

00387776516TRLO0.1.1

30/01/2024

09:59:19

986

198

XLON

00387776517TRLO0.1.1

30/01/2024

09:59:24

107

197.2

BATE

00387776582TRLO0.1.1

30/01/2024

09:59:24

67

197.2

BATE

00387776580TRLO0.1.1

30/01/2024

10:02:38

59

197.2

BATE

00387777718TRLO0.1.1

30/01/2024

10:06:08

31

197.2

BATE

00387778281TRLO0.1.1

30/01/2024

10:07:04

30

197.2

BATE

00387778397TRLO0.1.1

30/01/2024

10:09:53

1

197.2

BATE

00387778862TRLO0.1.1

30/01/2024

10:09:53

109

197.2

BATE

00387778863TRLO0.1.1

30/01/2024

10:09:53

84

197.2

BATE

00387778865TRLO0.1.1

30/01/2024

10:09:53

264

197.2

BATE

00387778864TRLO0.1.1

30/01/2024

10:11:29

1244

197

XLON

00387779158TRLO0.1.1

30/01/2024

10:11:29

131

197

TRQX

00387779159TRLO0.1.1

30/01/2024

10:11:29

732

197

XLON

00387779160TRLO0.1.1

30/01/2024

10:41:45

1482

196.6

XLON

00387790146TRLO0.1.1

30/01/2024

10:41:46

988

196.6

XLON

00387790149TRLO0.1.1

30/01/2024

11:01:25

9

196

AQXE

00387795688TRLO0.1.1

30/01/2024

11:25:49

237

196

AQXE

00387802101TRLO0.1.1

30/01/2024

11:25:49

246

196

AQXE

00387802100TRLO0.1.1

30/01/2024

11:25:49

131

196

TRQX

00387802102TRLO0.1.1

30/01/2024

11:25:49

1976

196

XLON

00387802103TRLO0.1.1

30/01/2024

11:25:49

550

195.2

BATE

00387802104TRLO0.1.1

30/01/2024

11:25:49

74

195.2

BATE

00387802105TRLO0.1.1

30/01/2024

11:25:49

365

195.2

CHIX

00387802106TRLO0.1.1

30/01/2024

11:25:49

16

195.2

BATE

00387802107TRLO0.1.1

30/01/2024

11:25:54

9

196

XLON

00387802122TRLO0.1.1

30/01/2024

11:25:54

354

196

XLON

00387802123TRLO0.1.1

30/01/2024

11:26:59

25

196

XLON

00387802420TRLO0.1.1

30/01/2024

11:33:38

385

196

XLON

00387804371TRLO0.1.1

30/01/2024

11:33:38

311

196

XLON

00387804372TRLO0.1.1

30/01/2024

12:44:07

18

195.2

BATE

00387822870TRLO0.1.1

30/01/2024

12:49:11

453

196

XLON

00387824722TRLO0.1.1

30/01/2024

13:30:05

9

195.4

AQXE

00387834713TRLO0.1.1

30/01/2024

13:50:26

131

196.8

TRQX

00387840429TRLO0.1.1

30/01/2024

14:17:04

41

197

XLON

00387850076TRLO0.1.1

30/01/2024

14:17:04

246

197

AQXE

00387850075TRLO0.1.1

30/01/2024

14:17:04

747

197

XLON

00387850077TRLO0.1.1

30/01/2024

14:17:04

254

197

XLON

00387850078TRLO0.1.1

30/01/2024

14:17:04

131

197

TRQX

00387850080TRLO0.1.1

30/01/2024

14:17:04

934

197

XLON

00387850079TRLO0.1.1

30/01/2024

14:30:03

303

198.8

XLON

00387855041TRLO0.1.1

30/01/2024

14:31:29

100

198.6

XLON

00387856310TRLO0.1.1

30/01/2024

14:53:45

3

198.8

CHIX

00387868446TRLO0.1.1

30/01/2024

14:54:38

246

198.2

AQXE

00387868821TRLO0.1.1

30/01/2024

14:54:38

246

198.2

AQXE

00387868822TRLO0.1.1

30/01/2024

14:54:38

131

198.2

TRQX

00387868823TRLO0.1.1

30/01/2024

14:54:38

2470

198.2

XLON

00387868824TRLO0.1.1

30/01/2024

14:54:38

131

198

TRQX

00387868825TRLO0.1.1

30/01/2024

14:54:45

123

198.4

CHIX

00387868865TRLO0.1.1

30/01/2024

14:54:45

106

198.4

CHIX

00387868866TRLO0.1.1

30/01/2024

14:54:45

391

198.6

CHIX

00387868867TRLO0.1.1

30/01/2024

14:54:45

350

198.8

CHIX

00387868868TRLO0.1.1

30/01/2024

14:55:02

35

198.4

BATE

00387868996TRLO0.1.1

30/01/2024

14:55:38

90

198.4

CHIX

00387869355TRLO0.1.1

30/01/2024

14:56:10

46

198.4

CHIX

00387869709TRLO0.1.1

30/01/2024

14:58:51

5580

199

XLON

00387871014TRLO0.1.1

30/01/2024

15:01:40

866

199.2

XLON

00387872765TRLO0.1.1

30/01/2024

15:03:02

12

198.6

AQXE

00387873913TRLO0.1.1

30/01/2024

15:06:59

95

198.6

AQXE

00387875706TRLO0.1.1

30/01/2024

15:08:43

460

199.2

XLON

00387876632TRLO0.1.1

30/01/2024

15:10:15

100

199.2

XLON

00387877502TRLO0.1.1

30/01/2024

15:10:17

2

199.2

CHIX

00387877511TRLO0.1.1

30/01/2024

15:12:05

13

198.6

AQXE

00387878410TRLO0.1.1

30/01/2024

15:15:04

117

198.6

AQXE

00387880083TRLO0.1.1

30/01/2024

15:15:05

15

199.2

XLON

00387880089TRLO0.1.1

30/01/2024

15:25:34

410

199.2

XLON

00387886172TRLO0.1.1

30/01/2024

15:40:57

800

199.2

XLON

00387894311TRLO0.1.1

30/01/2024

15:40:58

455

199.2

CHIX

00387894314TRLO0.1.1

30/01/2024

15:41:03

800

199.2

XLON

00387894379TRLO0.1.1

30/01/2024

15:51:45

10

198.4

AQXE

00387900310TRLO0.1.1

30/01/2024

15:56:32

42

198.4

AQXE

00387902910TRLO0.1.1

30/01/2024

15:56:32

194

198.4

AQXE

00387902911TRLO0.1.1

30/01/2024

15:56:32

131

198.4

TRQX

00387902913TRLO0.1.1

30/01/2024

15:56:32

108

198.4

AQXE

00387902912TRLO0.1.1

30/01/2024

15:56:32

40

198.4

TRQX

00387902914TRLO0.1.1

30/01/2024

15:56:32

29

198.4

TRQX

00387902915TRLO0.1.1

30/01/2024

15:56:32

79

198.4

XLON

00387902916TRLO0.1.1

30/01/2024

15:56:32

222

198.4

XLON

00387902917TRLO0.1.1

30/01/2024

15:56:32

957

198.4

XLON

00387902918TRLO0.1.1

30/01/2024

15:56:32

1212

198.4

XLON

00387902919TRLO0.1.1

30/01/2024

15:56:33

494

198

CHIX

00387902926TRLO0.1.1

30/01/2024

15:56:33

494

198

CHIX

00387902927TRLO0.1.1

30/01/2024

15:59:10

12

197.6

BATE

00387904266TRLO0.1.1

30/01/2024

15:59:10

77

197.6

BATE

00387904267TRLO0.1.1

30/01/2024

15:59:10

405

197.6

BATE

00387904268TRLO0.1.1

30/01/2024

15:59:11

519

197.8

CHIX

00387904276TRLO0.1.1

30/01/2024

15:59:11

2470

197.2

XLON

00387904277TRLO0.1.1

30/01/2024

15:59:13

9

197.2

CHIX

00387904343TRLO0.1.1

30/01/2024

16:02:56

354

198

XLON

00387907362TRLO0.1.1

30/01/2024

16:09:49

435

198.2

XLON

00387911189TRLO0.1.1

30/01/2024

16:09:53

215

198.2

CHIX

00387911230TRLO0.1.1

30/01/2024

16:09:55

79

198.2

XLON

00387911236TRLO0.1.1

30/01/2024

16:09:55

1268

198.2

XLON

00387911237TRLO0.1.1

30/01/2024

16:09:59

26

198.2

XLON

00387911278TRLO0.1.1

30/01/2024

16:09:59

98

198.2

XLON

00387911279TRLO0.1.1

30/01/2024

16:10:31

3

198.2

XLON

00387911599TRLO0.1.1

30/01/2024

16:10:42

354

198.2

XLON

00387911683TRLO0.1.1

30/01/2024

16:11:03

350

198.2

XLON

00387911917TRLO0.1.1

30/01/2024

16:11:41

12

198.2

XLON

00387912289TRLO0.1.1

30/01/2024

16:12:41

422

198.2

XLON

00387912792TRLO0.1.1

30/01/2024

16:14:18

351

198.2

XLON

00387913728TRLO0.1.1

30/01/2024

16:14:51

127

198.2

CHIX

00387914045TRLO0.1.1

30/01/2024

16:14:51

700

198.2

CHIX

00387914046TRLO0.1.1

30/01/2024

16:18:14

437

198.4

XLON

00387916024TRLO0.1.1

30/01/2024

16:18:14

124

198.4

XLON

00387916025TRLO0.1.1

30/01/2024

16:18:23

196

198.8

XLON

00387916156TRLO0.1.1

30/01/2024

16:18:29

124

198.8

XLON

00387916251TRLO0.1.1

30/01/2024

16:21:40

2400

198.8

XLON

00387918996TRLO0.1.1

30/01/2024

16:24:15

430

198.4

CHIX

00387920473TRLO0.1.1

30/01/2024

16:28:48

109

198.8

CHIX

00387923199TRLO0.1.1

30/01/2024

16:29:47

37

198.8

CHIX

00387924085TRLO0.1.1

30/01/2024

16:29:47

369

198.8

CHIX

00387924086TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFITLAIIVIS